Prostate cancer screening uptake rises 15% by 2026-12
Resolves: NHS England reports a 15% or greater increase in prostate cancer screening uptake (measured by number of appointment bookings) between July and December 2026 compared to the same period in 2025.
Prostate cancer screening uptake rises 15% by 2026-12
Market overview
The death of Dermot Murnaghan, an outspoken advocate for prostate cancer screening, is expected to drive awareness and increase early detection efforts. NHS England reported a 10% rise in screening appointments in the weeks following his diagnosis in 2025; a similar or higher surge is anticipated after his passing.
healthcare prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2026-12-31
About this prediction
Resolution criteria
NHS England reports a 15% or greater increase in prostate cancer screening uptake (measured by number of appointment bookings) between July and December 2026 compared to the same period in 2025.
Source: user-generated
More healthcare markets
- ACA enrollment drops exceed 3 million by Q4 2026 — 80% Yes
- Pediatrician visits for MMR split increase by 20% — 60% Yes
- Obamacare enrollment will fall below 10 million by 2027 — 75% Yes
- Obamacare enrollment in Ohio will drop by over 40% by 2028 — 70% Yes
- State-level Medicaid work requirements reduce enrollment by 15% — 70% Yes
- National Obamacare enrollment will drop below 10 million by 2027 — 80% Yes
- Medicaid work requirements reduce enrollment by 10% or more in 2026 — 68% Yes
- Ohio's Obamacare enrollment will further decline by 20% by 2027 — 75% Yes